So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...
Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...
MarketBeat on MSN16d
What Does the Future Hold for Eli Lilly?GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely the hottest medical sector story in 2024. With its offering of tirzepatide ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
A woman's hands star in a Lilly spot, shown playing key role in activities like gardening -- and discovering a lump in her ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Brand New Membership Level: Benzinga Trade Alerts Eli Lilly And Co LLY will announce its fourth-quarter 2024 financial results and 2025 financial guidance on February 6. As per data from Benzinga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback